Drug Search Results
More Filters [+]

Collagenase

Alternative Names: collagenase, santyl, qwo
Latest Update: 2024-07-10
Latest Update Note: Clinical Trial Update

Product Description

COLLAGENASE (kohl LAH jen ace) is an enzyme that breaks down collagen in damaged tissue and helps healthy tissue to grow. It may help wounds heal faster. (Sourced from: https://my.clevelandclinic.org/health/drugs/18678-collagenase-ointment)

Mechanisms of Action: MMP Inhibitor

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Topical,Injection

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Czech | Dominican Republic | Ecuador | Egypt | France | Germany | Hong Kong | Hungary | India | Ireland | Italy | Japan | Luxembourg | Malaysia | Mexico | Netherlands | New Zealand | Peru | Poland | Portugal | Russia | Slovakia | Slovenia | Spain | Switzerland | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela

Approved Indications: Cellulite

Known Adverse Events: Pain Unspecified | Erythema | Pruritus

Company: Endo
Company Location: DUBLIN 4 L2 00000
Company CEO: Blaise Coleman
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Collagenase

Countries in Clinic: Australia

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Dupuytren Contracture

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12624000664549

P2

Not yet recruiting

Dupuytren Contracture

2025-05-17

Vibrio alginolyticus collagenase Phase II

P2

Active, not recruiting

Dupuytren Contracture

2024-02-20

Recent News Events